Gustav Smith
Associate professor
Pharmacometabolomic Profiling Of The General Population: Relation Of Active Metabolite Levels To Cardiovascular Risk Factor Control And Manifest Atherosclerosis
Author
Summary, in English
Aim: 1. Prospective assessment of the proportion of measurable active metabolite levels of major drugs in the general population using mass spectrometry. 2. Relation of cardiovascular (CV) drugs with inadequate risk factor control and CV disease.
Methods: Assessment of CV risk factors by coronary CT angiography and carotid ultrasound imaging in a large prospective cohort of 6,251 individuals randomly selected from the general population in Malmö, Sweden (age 50-64 years). Untargeted metabolomic profiling of fasting plasma was performed by Metabolon, USA in a random subset of 3,986 subjects.
Results: Intake of at least one prescribed drug was reported in 1840 subjects (46%). Combination drugs were reported in 249 subjects (6%). The most common drug classes reported were lipid-lowering (n=369, 9% of which most were statins), beta blockers (n=307, 8%), ARB (n=272, 7%), and ACE inhibitors (268, 7%), followed by levothyroxine, CCB, antidepressants, glucocorticoids, PPI, antidiabetic, bronchodilators and diuretics. For major CV drugs, detectable active metabolite levels ranged from 54% (atorvastatin and enalapril) to 96% (metoprolol and metformin). Non-detectable levels of lipid-lowering, antihypertensive, and antidiabetic drugs were associated with higher LDL, cholesterol, BP and glucose, although only antidiabetic drugs were significant (p<0.05). Non-detectable levels of lipid-lowering and antihypertensive drugs were also non-significantly associated with increased coronary calcium and carotid plaque.
Conclusion: Our study provides an overview of the distribution of common drugs with detectable levels in a contemporary Swedish population. Pharmacometabolomic profiling revealed that non-measurable levels of common CV drugs were associated with lower risk factor control and non-significant trends towards more atherosclerotic disease by imaging in a substantial number of subjects.
Department/s
- Cardiovascular Research - Hypertension
- Molecular Epidemiology and Cardiology
- Cardiology
- EXODIAB: Excellence of Diabetes Research in Sweden
- Artificial Intelligence in CardioThoracic Sciences (AICTS)
- Thoracic Surgery
- Cardiovascular Research - Epidemiology
- EpiHealth: Epidemiology for Health
- WCMM-Wallenberg Centre for Molecular Medicine
- Heart Failure and Mechanical Support
- Cardiovascular Epigenetics
Publishing year
2021-11-08
Language
English
Publication/Series
Circulation
Volume
144
Issue
suppl_1
Links
Document type
Conference paper: abstract
Publisher
Lippincott Williams & Wilkins
Topic
- Clinical Medicine
- Cardiac and Cardiovascular Systems
Keywords
- Cardiology
- Metabolomics
- EPIDEMIOLOGY
- Atherosclerosis
- Cardiovascular risk factors
Conference name
American Heart Association (AHA), Scientific Session 2021
Conference date
2021-11-13 - 2021-11-15
Conference place
Boston, United States
Status
Published
Research group
- Cardiovascular Research - Hypertension
- Molecular Epidemiology and Cardiology
- Artificial Intelligence in CardioThoracic Sciences (AICTS)
- Cardiovascular Research - Epidemiology
- Heart Failure and Mechanical Support
- Cardiovascular Epigenetics
ISBN/ISSN/Other
- ISSN: 1524-4539